No Data
No Data
Earnings Update: Here's Why Analysts Just Lifted Their Sangamo Therapeutics, Inc. (NASDAQ:SGMO) Price Target To US$3.80
Q2 2024 Sangamo Therapeutics Inc Earnings Call
Earnings Call: Sangamo Therapeutics Extends Cash Runway Into 2025
RBC Capital Remains a Hold on Sangamo Biosciences (SGMO)
Roche Strikes New Deal With Sangamo to Tackle Alzheimer's
Sangamo Therapeutics, Inc. (SGMO) Q2 2024 Earnings Call Transcript